Germany’s Merck suffers setback with cancer drug
BERLIN (AP) ? German pharmaceutical company Merck KgaA says a late stage trial of a new lung cancer drug has failed to meet expectations.
View full post on Health News Headlines – Yahoo! News
BERLIN (AP) ? German pharmaceutical company Merck KgaA says a late stage trial of a new lung cancer drug has failed to meet expectations.
View full post on Health News Headlines – Yahoo! News
You must be logged in to post a comment.
Leave a Reply